Get the app
public
ios_share
OncoPharm
chevron_right
ESMO 2022 - NICHE-2 and Codebreak 200
Sep 15, 2022
11:41
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
ESMO 2022 is wrapped and two studies in particular have caught our eyes: NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer CODEBREAK: sotorasib vs. docetaxel